BrainWavesAI

AI-based Technology for Continuous Monitoring and Prediction of Epileptic Seizures

Health Tech & Life Sciences
Non Active, Sep 2024 ceased to operate

Company Overview

Snapshot

Founded in April 2021 by Dr. David Kahn, BrainWavesAI operates with a small team of 1–10 employees. The company is currently in a Pre-Funding stage.

Business overview

BrainWavesAI develops artificial intelligence and deep-learning technologies to analyze electroencephalogram data for predictive monitoring solutions. The company's core technology focuses on real-time monitoring of brain electrical activity to predict the risk of epileptic seizures, providing alerts for mitigating action. BrainWavesAI serves the health tech and life sciences sectors, specifically within digital healthcare, medical devices, and patient remote monitoring, with a primary market in the United States.

Company Intelligence Q&A

What is BrainWavesAI's primary focus?
BrainWavesAI focuses on utilizing artificial intelligence and deep-learning to provide continuous monitoring and prediction of epileptic seizures, aiming to improve mental health and wellbeing.
When was BrainWavesAI founded?
BrainWavesAI was founded in April 2021.
Who is a co-founder of BrainWavesAI?
Dr. David Kahn is a co-founder of BrainWavesAI.
What is the current status of BrainWavesAI?
BrainWavesAI is currently non-active, having ceased to operate in September 2024.
Which markets does BrainWavesAI target?
BrainWavesAI targets geomarkets including the United States.

External links